EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype-First Approach Identifies an Association between rs28374544/FOG2S657G and Liver Disease through Alterations in mTORC1 Signaling

Donna M Conlon, Siri Kanakala, Tess Cherlin iD, Yi-An Ko, Cecilia Vitali, Sharavana Gurunathan iD, Rasika Venkatesh iD, Jakob Woerner, Lindsay A Guare iD, Penn Medicine Biobank, Anurag Verma, Shefali S Verma und 1 weitere

Genes · 2024

DOI: 10.3390/genes15081098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Donna M Conlon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3400 Civic Center Blvd., Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Signal Transduction, Transcription Factors, DNA-Binding Proteins. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Burroughs Wellcome Fund, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated Fatty Liver Disease (MAFLD) has emerged as one of the leading cardiometabolic diseases. Friend of GATA2 (FOG2) is a transcriptional co-regulator that has been shown to regulate hepatic lipid metabolism and accumulation. Using meta-analysis from several different biobank datasets, we identified a coding variant of FOG2 (rs28374544, A1969G, S657G) predominantly found in individuals of African ancestry (minor allele frequency~20%), which is associated with liver failure/cirrhosis phenotype and liver injury. To gain insight into potential pathways associated with this variant, we interrogated a previously published genomics dataset of 38 human induced pluripotent stem cell (iPSCs) lines differentiated into hepatocytes (iHeps). Using Differential Gene Expression Analysis and Gene Set Enrichment Analysis, we identified the mTORC1 pathway as differentially regulated between iHeps from individuals with and without the variant. Transient lipid-based transfections were performed on the human hepatoma cell line (Huh7) using wild-type FOG2 and FOG2S657G and demonstrated that FOG2S657G increased mTORC1 signaling, de novo lipogenesis, and cellular triglyceride synthesis and mass. In addition, we observed a significant downregulation of oxidative phosphorylation in FOG2S657G cells in fatty acid-loaded cells but not untreated cells, suggesting that FOG2S657G may also reduce fatty acid to promote lipid accumulation. Taken together, our multi-pronged approach suggests a model whereby the FOG2S657G may promote MAFLD through mTORC1 activation, increased de novo lipogenesis, and lipid accumulation. Our results provide insights into the molecular mechanisms by which FOG2S657G may affect the complex molecular landscape underlying MAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Signal TransductionTranscription FactorsDNA-Binding ProteinsHumansHepatocytesPolymorphism, Single NucleotideInduced Pluripotent Stem CellsLipid MetabolismCell Line, TumorGenotypeLiver Diseases

Stichwörter der Autor:innen

FOG2Functional GenomicsMAFLDmTORC1

Substanzen

Mechanistic Target of Rapamycin Complex 1Transcription FactorsZFPM2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Medicine, University of Pennsylvania Perelman School of Medicine, 3400 Civic Center Blvd., Philadelphia, PA 19104, USA.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Tess Cherlin, Sharavana Gurunathan, Rasika Venkatesh, Lindsay A Guare

Förderung

  • NIDDK NIH HHS
  • Burroughs Wellcome Fund
  • NIH HHS
  • NIH Center
  • NIH grant

Zitieren

APA

Conlon, D. M., Kanakala, S., Cherlin, T., Ko, Y. A., Vitali, C., Gurunathan, S., Venkatesh, R., Woerner, J., Guare, L. A., Biobank, P. M., Verma, A., Verma, S. S., & Guerraty, M. A. (2024). Genotype-First Approach Identifies an Association between rs28374544/FOG2S657G and Liver Disease through Alterations in mTORC1 Signaling. Genes. https://doi.org/10.3390/genes15081098

Vancouver

Conlon DM, Kanakala S, Cherlin T, Ko YA, Vitali C, Gurunathan S, et al. Genotype-First Approach Identifies an Association between rs28374544/FOG2S657G and Liver Disease through Alterations in mTORC1 Signaling. Genes. 2024. doi:10.3390/genes15081098

BibTeX
@article{Conlon2024,
  author = {Conlon, Donna M and Kanakala, Siri and Cherlin, Tess and Ko, Yi-An and Vitali, Cecilia and Gurunathan, Sharavana and Venkatesh, Rasika and Woerner, Jakob and Guare, Lindsay A and Biobank, Penn Medicine and Verma, Anurag and Verma, Shefali S and Guerraty, Marie A},
  title = {Genotype-First Approach Identifies an Association between rs28374544/FOG2S657G and Liver Disease through Alterations in mTORC1 Signaling},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15081098}
}
Kostenlos starten →